| Literature DB >> 21076521 |
Konstantis F Konidaris1, Rigini Papi, Eugenia Katsoulakou, Catherine P Raptopoulou, Dimitrios A Kyriakidis, Evy Manessi-Zoupa.
Abstract
The employment of class="Chemical">3-pyridine aldoxime, <class="Chemical">span class="Chemical">(3-py)CHNOH, in Zn(II) chemistry has afforded two novel compounds: [Zn(acac)(2){(3-py)CHNOH}]·H(2)O (1·H(2)O) [where acac(-) is the pentane-2,4-dionato(-1) ion] and [Zn(2)(O(2)CMe)(4){(3-py)CHNOH}(2)] (2). Complex 1·H(2)O crystallizes in the monoclinic space group P2(1)/n. The Zn(II) ion is five-coordinated, surrounded by four oxygen atoms of two acac(-) moieties and by the pyridyl nitrogen atom of the (3-py)CHNOH ligand. Molecules of 1 interact with the water lattice molecules forming a 2D hydrogen-bonding network. Complex 2 crystallizes in the triclinic P-1 space group and displays a dinuclear paddle-wheel structure. Each Zn(II) exhibits a perfect square pyramidal geometry, with four carboxylate oxygen atoms at the basal plane and the pyridyl nitrogen of one monodentate (3-py)CHNOH ligand at the apex. DNA mobility shift assays were performed for the determination of the in vitro effect of both complexes on the integrity and the electrophoretic mobility of pDNA.Entities:
Year: 2010 PMID: 21076521 PMCID: PMC2971566 DOI: 10.1155/2010/803424
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Structural formula and abbreviation of the ligand employed in this work.
Crystallographic data for complexes 1·H2O and 2.
| Parameter |
|
|
|---|---|---|
| Formula | C16H22N2O6Zn | C20H24N4O10Zn2 |
| Fw | 403.73 | 611.17 |
| Space group |
|
|
|
| 10.531(4) | 7.934(5) |
|
| 15.779(5) | 10.153(6) |
|
| 11.602(4) | 8.392(5) |
|
| 90 | 70.05(2) |
|
| 101.17(1) | 87.34(2) |
|
| 90 | 89.07(3) |
|
| 1891.4(11) | 634.8(7) |
| Z | 4 | 1 |
|
| 25 | 25 |
| Radiation | Mo K | Cu K |
|
| 1.418 | 1.599 |
|
| 1.331 | 2.856 |
| Reflections with | 2865 | 1585 |
|
| 0.0302 | 0.0438 |
|
| 0.0785 | 0.1125 |
w = 1/[σ 2(F 2) + (α P)2 + b P] and P = (max F o 2, 0) + 2F c 2)/3
R 1 = Σ(|F o|-|F o|)/Σ(|F o|) and w R 2 = {Σ[w(F o 2-F 2)2]/Σ[w(F o 2)2]}1/2.
Figure 1Partially labeled plot of the molecular structure of 1·H2O. H atoms and the solvate H2O molecule have been omitted for clarity.
Figure 4A small portion of the ladder-like 1D architectures of 2 due to H-bonding interactions (black dashed lines). The H atoms have been omitted for clarity.
Selected interatomic distances (Å) and angles (°) for complex 1·H2O.
| Zn-O(2) | 2.055(2) | Zn-O(3) | 1.988(2) |
| Zn-O(4) | 2.029(2) | Zn-O(5) | 2.000(2) |
| Zn-N(1) | 2.073(2) | ||
|
| |||
| O(3)-Zn-O(5) | 137.1(9) | O(4)-Zn-O(2) | 169.1(8) |
| O(3)-Zn-O(4) | 88.5(8) | O(3)-Zn-N(1) | 113.1(8) |
| O(5)-Zn-O(4) | 89.6(7) | O(5)-Zn-N(1) | 109.7(8) |
| O(3)-Zn-O(2) | 89.00(8) | O(4)-Zn-N(1) | 94.5(8) |
| O(5)-Zn-O(2) | 85.1(7) | O(2)-Zn-N(1) | 96.3(7) |
Selected interatomic distances (Å) and angles (°) for complex 2 .
| Zn-O(2) | 2.088(3) | Zn-O(4) | 2.016(3) |
| Zn-O(3′) | 2.055(3) | Zn-O(5′) | 2.016(3) |
| Zn-N(1) | 2.049(4) | Zn⋯Zn′ | 2.923(2) |
|
| |||
| O(4)-Zn-O(5′) | 159.9(1) | N(1)-Zn-O(3′) | 101.4(1) |
| O(4)-Zn-N(1) | 100.4(1) | O(4)-Zn-O(2) | 87.0(1) |
| O(5′)-Zn-N(1) | 99.6(1) | O(5′)-Zn-O(2) | 90.2(1) |
| O(4)-Zn-O(3′) | 88.1(2) | N(1)-Zn-O(2) | 98.4(1) |
| O(5′)-Zn-O(3′) | 87.8(1) | O(3′)-Zn-O(2) | 160.2(1) |
aSymmetry transformations used to generate equivalent atoms: (′)-x, 1-y, −z.
Hydrogen bonding interactions in 1·H2O and 2.
| InteractionaD-H⋯A | D⋯A (Å) | H⋯A (Å) | D-H⋯A (°) | Symmetry operation of A |
|---|---|---|---|---|
|
| ||||
| O(1W)-H(1WA)⋯O(2) | 3.002 | 2.5600 | 115.0 | 1/2 − |
| O(1)-H(1O)⋯O(1W) | 2.663 | 1.970 | 168.0 | 1 − |
| O(1W)-H(1WB)⋯N(2) | 3.002 | 2.300 | 145.0 |
|
|
| ||||
| O(1)-H(1O)⋯O2 | 2.712 | 1.910 | 166.0 |
|
aA = acceptor, D = donor.
Figure 2A part of the 2D network in the crystal lattice of 1·H2O due to hydrogen bonding interactions (dashed lines). Oxygen atoms of the water lattice molecules are represented by blue spheres.
Figure 5Agarose gel electrophoresis pattern of pDNA in the presence of the synthesized complexes and (3-py)CHNOH in various concentrations. Lane 1, DNA + 1·H2O (5 mM); lane 2, DNA + 2 (5 mM); lane 3, DNA+ (3-py)CHNOH (5 mM); lane 4, DNA + 1·H2O (2.5 mM); lane 5, DNA + 2 (2.5 mM); lane 6, DNA + (3-py)CHNOH (2.5 mM); lane 7, DNA + 1·H2O (1 mM); lane 8, DNA + 2 (1 mM); lane 9, DNA + 1·H2O (0.1 mM); lane 10, DNA + 2 (0.1 mM); lane 11, DNA control.